DNA- and mRNA-based therapeutic cancer vaccines for oncology and immunology applications
Investors 2
| Date | Name | Website |
| 21.09.2026 | MINT Ventu... | mintventur... |
| - | SBI Invest... | sbik.co.kr |
Mentions in press and media 1
| Date | Title | Description |
| 05.09.2022 | Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer | - CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, received U.S. FDA approval for Phase 2 trial following the approvals in Australia and the Taiwan region. - As the same patient group and design of... |